MAW and SJ are employees of AstraZeneca R&D Mölndal, Sweden. AstraZeneca manufactures rosuvastatin.
Version of Record online: 21 APR 2008
Copyright © 2008 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 17, Issue 10, pages 953–961, October 2008
How to Cite
García-Rodríguez, L. A., González-Pérez, A., Stang, M. R., Wallander, M.-A. and Johansson, S. (2008), The safety of rosuvastatin in comparison with other statins in over 25 000 statin users in the Saskatchewan Health Databases. Pharmacoepidem. Drug Safe., 17: 953–961. doi: 10.1002/pds.1602
LAGR and AGP are employed by CEIFE, which has received research grants from AstraZeneca.
- Issue online: 24 SEP 2008
- Version of Record online: 21 APR 2008
- Manuscript Accepted: 9 MAR 2008
- Manuscript Received: 29 FEB 2008
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.